Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Delcath Systems issues third quarter update
December 24th, 2006
Delcath Systems, Inc. (DCTH) issued the following third quarter update to shareholders from M.S. Koly, president and chief executive officer. Dear Fellow Delcath Shareholders: I would like to thank my fellow shareholders for their support during the recent months. We look forward to continuing to focus on the advancement of the Delcath system through the Phase III clinical trials, FDA approval and into commercialization. Our accomplishments for the quarter have included, continued progress in our pivotal Phase-III studies using melphalan and doxorubicin, expanding our management team, adding two new board of directors, and hiring a nationally...
Source: Medical Devices & Surgical Technology Week (2006-12-24)
|
